NCT03916224 (INTUPROS) is a clinical trial in Intubation; Difficult or Failed, sponsored by Spanish Network for Research in Infectious Diseases.

Who is sponsoring NCT03916224?

NCT03916224 is sponsored by Spanish Network for Research in Infectious Diseases.

What condition does NCT03916224 study?

NCT03916224 studies Intubation; Difficult or Failed, Intubation Complication, Intubation.

Is NCT03916224 still recruiting?

NCT03916224 is currently completed. Last updated 2 April 2021.

Last reviewed 2021-04-02 · How we verify

NCT03916224: INTUPROS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Adverse Events in the Tracheal Intubation in the Intensive Care Unit

Completed Last updated 2 April 2021

What this trial tests

trial in Intubation; Difficult or Failed in 1,800 participants. Completed in 31 October 2020.

Timeline

15 April 2019

Primary endpoint
31 October 2020

31 October 2020

Quick facts

Lead sponsor	Spanish Network for Research in Infectious Diseases
Status	Completed
Study type	OBSERVATIONAL
Enrollment	1,800
Start date	15 April 2019
Primary completion	31 October 2020
Estimated completion	31 October 2020
Sites	1 location across Spain

Conditions studied

Intubation; Difficult or Failed — all drugs for Intubation; Difficult or Failed →
Intubation Complication — all drugs for Intubation Complication →
Intubation — all drugs for Intubation →

Sponsor

Spanish Network for Research in Infectious Diseases

Who can join

18 and older, any sex, with Intubation; Difficult or Failed or Intubation Complication. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The airway management is essential in the Critical Care setting, both normal and difficult airway patients. Intubation is a risk procedure in which a great number of complications may occur, including death. The poor physiological reserve of critical patients may suppose an additional handicap to carry out successfully intubation. The purpose of this study is to analyze the prevalence and risk factors for major complications in the intubation process in the Intensive Care Unit (ICU). In addition, the investigators will assess the impact of preoxygenation and the use of videolaryngoscope on the occurrence of major and minor complications. Finally, this study will review the drug protocols used in each participant ICU during intubation process.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

ESICM LIVES 2022: part 1.
· 2022 · cited 4× · PMID 36258101 · DOI 10.1186/s40635-022-00468-1
A Nationwide, Prospective Study of Tracheal Intubation in Critically Ill Adults in Spain: Management, Associated Complications, and Outcomes
Garnacho-Montero J, Gordillo-Escobar E, Trenado J, Gordo F, et al · · 2022 · DOI 10.2139/ssrn.4123267

Verify or expand the search:

Other recruiting trials for Intubation; Difficult or Failed

Currently open trials in the same condition.

NCT07493356 — Difficult Airway Prediction by Integrating STOP-BANG Criteria · recruiting
NCT06453525 — PrediSuisse: Automatized Assessment of Difficult Airway · recruiting
NCT05927519 — Comparison of Airtraq in Class 2-3 Obese and Nonobese Men During Intubation: a Prospective Randomized Clinical Study · NA · recruiting
NCT06322719 — Hyperangulated vs Macintosh Blades for Intubation With Videolaryngoscopy in ICU · NA · recruiting
NCT05884645 — The DAnish VIdeo IntubaTION (DA-VITION) Study · recruiting

Other Spanish Network for Research in Infectious Diseases trials

Trials by the same sponsor.

NCT03104933 — Proadrenomedullin and Copeptin in Patients With Septic Shock · completed
NCT02852902 — Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to ESBL- or Carbapenemase- · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03916224 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Spanish Network for Research in Infectious Diseases
Last refreshed: 2 April 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03916224.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing